Morgan Stanley Maintains Equal-Weight on Clarivate, Lowers Price Target to $9
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Toni Kaplan has maintained an Equal-Weight rating on Clarivate (NYSE:CLVT) and lowered the price target from $11 to $9.
August 04, 2023 | 4:50 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley has maintained an Equal-Weight rating on Clarivate and lowered the price target from $11 to $9.
The lowering of the price target by Morgan Stanley from $11 to $9 indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on Clarivate's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100